A New Approach to Partnering Opens Up New Growth Alternatives for Pharmaceutical and Biotechnology Companies

Each year, the strategic and financial challenges faced by pharmaceutical and biotech companies grow and change: maximizing investment needed for the future and dealing with the escalating risk and cost of development, all within the context of infrastructure and financial pressures.

Strategic investment partnerships are increasingly seen as the best way to break through the logjam of resource constraints. NovaQuest exists to provide alternative growth strategies designed around partners’ specific challenges and goals, and offers advantages over both purely financial investors and typical industry partnership models because of our:

• World-class product development and commercialization expertise from Quintiles and Innovex
• Years of understanding and experience in structuring customized co-development and co-promotion partnerships
• The operational and financial flexibility to craft investment partnerships uniquely suited to different needs
• Access to the healthcare industry and investment expertise of TPG-Axon Capital, as well as access to significant capital through an exclusive partnership
• The willingness to contribute Quintiles value-added expertise to product programs without requiring partners to give up strategic program control

Each alliance is a unique response to a partner’s needs, so no general description will address your specific challenges as directly as NovaQuest will face to face. Let us discuss these issues with you and together discover what is possible.

And show you why NovaQuest is the smarter way to partner.

Contact Us

1 919 998 2000